
CONTACT INFORMATION

Specialties
Prostate Cancer, Breast Cancer, Gastrointestinal cancers, General Oncology
Board Certifications
Hematology - Subspecialty Cert: AM Board of Internal Medicine
Internal Medicine - General Cert: AM Board of Internal Medicine
Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Publications
Combination of notch inhibitor MK-0752 and endocrine therapy for early stage ERa+ breast cancer in a presurgical window pilot studyAlbain,K. S.; Czerlanis,C.; Rajan,P.; Zlobin,A.; Godellas,C.; Bova,D.; Lo,S. S.; Robinson,P.; Sarker,S.; Gaynor,E. R.; Cooper,R.; Aranha,G.; Czaplicki,K.; Busby,B.; Rizzo,P.; Chisamore,M.; Demuth,T.; Blackman,S.; Watters,J.; Stiff,P.; Fuqua,S. A. W.; Miele,L.33rd Annual San Antonio Breast Cancer Symposium 2010 ; ( ):
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.Lo,S. S.; Mumby,P. B.; Norton,J.; Rychlik,K.; Smerage,J.; Kash,J.; Chew,H. K.; Gaynor,E. R.; Hayes,D. F.; Epstein,A.; Albain,K. S.JOURNAL OF CLINICAL ONCOLOGY 2010 ;28(10):1671-1676
Octreotide for refractory diarrhea associated with capecitabineTanvetyanon,T.; Gaynor,E. R.Journal of Pharmacy Technology 2004 ;20(4):226-228
Education
Medical School
University of Wisconsin Medical School
Residency
Loyola University Medical Center, Internal Medicine: General
Loyola University Medical Center, Internal Medicine: General
Fellowship
Loyola University Medical Center, Internal Medicine: Medical Oncology
University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology